DBV Technologies S.A. (DBVT) Social Stream



DBV Technologies S.A. (DBVT): $0.60

0.04 (+6.43%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add DBVT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#161 of 357

in industry

DBV TECHNOLOGIES SA (DBVT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering DBV TECHNOLOGIES SA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-27 1 $14 $2 $8 $0.872 817.43%
2021-12-21 2 $10 $2 $5.666 $0.872 549.77%
2022-05-03 3 $10 $5 $7.5 $0.872 760.09%
2022-11-04 3 $10 $1.5 $5.75 $0.872 559.4%
2023-05-09 4 $10 $1.5 $5.166 $0.872 492.43%
2023-08-01 4 $10 $4 $7 $0.872 702.75%
2023-11-02 4 $10 $1 $5 $0.872 473.39%

The Trend in the Analyst Price Target


DBVT's average price target has moved down $0.62 over the prior 37 months.

DBVT reports an average of 289.75% for its upside potential over the past 35 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-08 4 10 1.5 5.166 1.73 198.61%
2023-05-09 4 10 1.5 5.166 1.63 216.93%
2023-05-09 4 10 4.0 7.000 1.63 329.45%
2023-08-01 4 10 4.0 7.000 1.61 334.78%
2023-11-02 4 10 1.0 5.000 1.00 400%

DBVT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 3 0 0 1 1 4

The Trend in the Broker Recommendations


DBVT's average broker recommendation rating worsened by 0.69 over the prior 45 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, DBV TECHNOLOGIES SA's upside potential (average analyst target price relative to current price) is higher than 1045.84% of them.
  • DBVT has a greater average analyst price target than 62.62% of all US stocks.
  • DBV TECHNOLOGIES SA's number of analysts covering the stock is greater than 70.5% of all US stocks.
  • DBV TECHNOLOGIES SA's variance in analysts' estimates is lower than -872.15% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to DBV TECHNOLOGIES SA are EIGR, OCGN, and ADVM.

Make investment decisions regarding DBVT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!